- Home
- Publications
- Publication Search
- Publication Details
Title
White paper on microbial anti-cancer therapy and prevention
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 6, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-06
DOI
10.1186/s40425-018-0381-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tolerability of ADXS11-001 Lm -LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer
- (2018) Howard Safran et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene
- (2018) Matthew Marr et al. Viruses-Basel
- The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer
- (2017) Adrian G. Murphy et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
- (2017) Suzanne George et al. IMMUNITY
- Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
- (2017) Zin W. Myint et al. Journal of Hematology & Oncology
- Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
- (2017) James L. Gulley et al. JNCI-Journal of the National Cancer Institute
- Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
- (2017) Nicholas M. Durham et al. MOLECULAR THERAPY
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
- (2017) Jianjun Gao et al. NATURE MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolutionary Origins of cGAS-STING Signaling
- (2017) Shally R. Margolis et al. TRENDS IN IMMUNOLOGY
- Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours
- (2017) C. C. Hwang et al. Veterinary and Comparative Oncology
- Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
- (2017) Assia Angelova et al. Viruses-Basel
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect
- (2017) Dinesh Chandra et al. Oncotarget
- Review: Oncolytic virotherapy, updates and future directions
- (2017) Christos Fountzilas et al. Oncotarget
- Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
- (2017) Margaret E. Gatti-Mays et al. Human Vaccines & Immunotherapeutics
- How to develop viruses into anticancer weapons
- (2017) Roberto Cattaneo et al. PLoS Pathogens
- Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
- (2017) James L. Gulley et al. JNCI-Journal of the National Cancer Institute
- Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors
- (2017) Alicia M. Waters et al. Human Gene Therapy Clinical Development
- Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy
- (2017) Mark Bazett et al. OncoImmunology
- Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms
- (2017) Arthee Jahangir et al. OncoImmunology
- Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis
- (2017) Desislava Tsoneva et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Current progress in immunotherapy for pancreatic cancer
- (2016) Kelly Foley et al. CANCER LETTERS
- Genetically engineered mouse models in oncology research and cancer medicine
- (2016) Kelly Kersten et al. EMBO Molecular Medicine
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Standardized large-scale H-1PV production process with efficient quality and quantity monitoring
- (2016) Barbara Leuchs et al. JOURNAL OF VIROLOGICAL METHODS
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma
- (2016) M Kazim Panjwani et al. MOLECULAR THERAPY
- Synchronized cycles of bacterial lysis for in vivo delivery
- (2016) M. Omar Din et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Cancer immunology and canine malignant melanoma: A comparative review
- (2016) Matthew J. Atherton et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Cancer immunotherapy in veterinary medicine: Current options and new developments
- (2016) Daniel Regan et al. VETERINARY JOURNAL
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies
- (2016) Juan J. Rojas et al. Cell Reports
- Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy
- (2016) Jun Ren et al. OncoImmunology
- Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
- (2016) Guy Ungerechts et al. Molecular Therapy-Methods & Clinical Development
- Canine cancer immunotherapy studies: linking mouse and human
- (2016) Jiwon S. Park et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
- (2015) A. H. Rook et al. BLOOD
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Induction of CD4+and CD8+anti-tumor effector T cell responses by bacteria mediated tumor therapy
- (2015) Christian Stern et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Vaccines To Potentiate the Effective CD103+Dendritic Cell–Mediated Cross-Priming of Antitumor Immunity
- (2015) Yi Zhang et al. JOURNAL OF IMMUNOLOGY
- In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
- (2015) Linda Hammerich et al. Molecular Oncology
- Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
- (2015) Laura Evgin et al. MOLECULAR THERAPY
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
- (2015) P. H. Lizotte et al. Nature Nanotechnology
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
- (2015) Ashish M. Kamat et al. Nature Reviews Urology
- Quorum-sensingSalmonellaselectively trigger protein expression within tumors
- (2015) Charles A. Swofford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Oncolytic parvoviruses: from basic virology to clinical applications
- (2015) Antonio Marchini et al. Virology Journal
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats
- (2015) Verena Staedtke et al. Oncotarget
- Tunable pH-Responsive Polymeric Micelle for Cancer Treatment
- (2015) Xiaolan Zhang et al. ACS Macro Letters
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- Trial Watch—Oncolytic viruses and cancer therapy
- (2015) Jonathan Pol et al. OncoImmunology
- Identification ofStaphylococcus aureusα-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells
- (2014) Charles A. Swofford et al. BIOTECHNOLOGY AND BIOENGINEERING
- Imaging tumour hypoxia with positron emission tomography
- (2014) I N Fleming et al. BRITISH JOURNAL OF CANCER
- Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy
- (2014) M Singh et al. BRITISH JOURNAL OF CANCER
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Viruses for Tumor Therapy
- (2014) John Bell et al. Cell Host & Microbe
- Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors
- (2014) V. Roulstone et al. CLINICAL CANCER RESEARCH
- Salmonella as an Innovative Therapeutic Antitumor Agent
- (2014) Wen-Wei Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus
- (2014) Elizabeth Ilett et al. MOLECULAR THERAPY
- Bacterial Delivery of Staphylococcus aureus α-Hemolysin Causes Regression and Necrosis in Murine Tumors
- (2014) Adam T St. Jean et al. MOLECULAR THERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
- (2014) N. J. Roberts et al. Science Translational Medicine
- Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies
- (2014) Barbara R. Tschida et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer
- (2014) Carolina S. Ilkow et al. PLoS Pathogens
- Myeloid-derived suppressor cells
- (2014) Dinesh Chandra et al. OncoImmunology
- AttenuatedListeria monocytogenesreprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis
- (2014) Patrick H Lizotte et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
- (2014) Dmitriy Zamarin et al. Molecular Therapy-Oncolytics
- Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
- (2013) D Chandra et al. BRITISH JOURNAL OF CANCER
- Oncolytic vaccines
- (2013) Noura B Elsedawy et al. Expert Review of Vaccines
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Lipid A controls the robustness of intratumoral accumulation of attenuatedSalmonellain mice
- (2013) Miaomin Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic targeting of chitosan–PEG–folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy
- (2013) Oh-Joon Kwon et al. JOURNAL OF CONTROLLED RELEASE
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound
- (2013) Robert Carlisle et al. JNCI-Journal of the National Cancer Institute
- New viruses for cancer therapy: meeting clinical needs
- (2013) Tanner S. Miest et al. NATURE REVIEWS MICROBIOLOGY
- Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer
- (2013) W. Quispe-Tintaya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
- (2013) K Kono et al. Cell Death & Disease
- Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs
- (2013) Amy K. LeBlanc et al. Human Gene Therapy Clinical Development
- Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
- (2012) Balveen Kaur et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Pathogen-Specific Inflammatory Milieux Tune the Antigen Sensitivity of CD8+ T Cells by Enhancing T Cell Receptor Signaling
- (2012) Martin J. Richer et al. IMMUNITY
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- Gene therapy for brain tumors: Basic developments and clinical implementation
- (2012) Hikmat Assi et al. NEUROSCIENCE LETTERS
- Evaluation ofClostridium novyi–NT spores in dogs with naturally occurring tumors
- (2011) Erika L. Krick et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis
- (2011) S Ganai et al. CANCER GENE THERAPY
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
- (2011) E. Antonio Chiocca et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Increasing vaccine potency through exosome antigen targeting
- (2011) Zachary C. Hartman et al. VACCINE
- Magnetic resonance imaging of tumor necrosis
- (2010) Tormod A. M. Egeland et al. ACTA ONCOLOGICA
- Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer
- (2010) N Kashiwagi et al. BRITISH JOURNAL OF RADIOLOGY
- Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human
- (2010) V Shahabi et al. CANCER GENE THERAPY
- Ligand-Independent Toll-like Receptor Signals Generated by Ectopic Overexpression of MyD88 Generate Local and Systemic Antitumor Immunity
- (2010) Z. C. Hartman et al. CANCER RESEARCH
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Efficient Eradication of Subcutaneous but Not of Autochthonous Gastric Tumors by Adoptive T Cell Transfer in an SV40 T Antigen Mouse Model
- (2010) C. Bourquin et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Tumor Growth and Metastasis by a Combination of Escherichia coli –mediated Cytolytic Therapy and Radiotherapy
- (2010) Sheng-Nan Jiang et al. MOLECULAR THERAPY
- Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy
- (2010) G. Elizabeth Pluhar et al. VACCINE
- Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
- (2009) S Ganai et al. BRITISH JOURNAL OF CANCER
- High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action
- (2009) S. H. Kim et al. CANCER RESEARCH
- Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
- (2009) V. H. Nguyen et al. CANCER RESEARCH
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
- (2009) Ravi A Madan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
- (2009) R M Ryan et al. GENE THERAPY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The origin and development of nonlymphoid tissue CD103+DCs
- (2009) Florent Ginhoux et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
- (2009) M. M. Seavey et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Adenovirus Activates Complement by Distinctly Different Mechanisms In Vitro and In Vivo: Indirect Complement Activation by Virions In Vivo
- (2009) J. Tian et al. JOURNAL OF VIROLOGY
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
- The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
- (2009) Paulo Cesar Maciag et al. VACCINE
- Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
- (2008) Z. Sheng Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Prodrug converting enzyme gene delivery by L. monocytogenes
- (2008) Jochen Stritzker et al. BMC CANCER
- Salmonella Promoters Preferentially Activated Inside Tumors
- (2008) N. Arrach et al. CANCER RESEARCH
- Containment of Tumor-Colonizing Bacteria by Host Neutrophils
- (2008) K. Westphal et al. CANCER RESEARCH
- Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery
- (2008) S H Thorne et al. GENE THERAPY
- Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma
- (2008) Brent S. Sorenson et al. JOURNAL OF PEDIATRIC SURGERY
- Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand
- (2008) Markus Loeffler et al. JNCI-Journal of the National Cancer Institute
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
- Virotherapy of Ovarian Cancer With Polymer-cloaked Adenovirus Retargeted to the Epidermal Growth Factor Receptor
- (2007) Joanne Morrison et al. MOLECULAR THERAPY
- Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
- (2007) Amy B. Heimberger et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More